Type 2 Diabetes
Overview of Type 2 Diabetes
Type 2 diabetes is a chronic condition characterized by:
Insulin Resistance: The body’s cells become less responsive to insulin, leading to elevated blood glucose levels.
Impaired Insulin Production: Over time, the pancreas struggles to produce enough insulin to maintain normal blood sugar levels.
Stem Cell Treatment Mechanism
Stem cell therapy aims to address the fundamental problems associated with type 2 diabetes through several mechanisms:
Regeneration of Beta Cells:
Beta Cells: These are insulin-producing cells in the pancreas. In type 2 diabetes, their function is often compromised.
Stem cells can potentially differentiate into new beta cells or support the repair of existing ones, enhancing insulin production.
Reduction of Inflammation:
Chronic inflammation is associated with insulin resistance. Certain types of stem cells, like mesenchymal stem cells (MSCs), have anti-inflammatory properties that may help reduce inflammation and improve insulin sensitivity.
Improvement of Insulin Sensitivity:
By addressing the underlying factors of insulin resistance, stem cell therapy may enhance the body's response to insulin, leading to better glucose uptake by cells.
Types of Stem Cells Used
Mesenchymal Stem Cells (MSCs):
Known for their ability to modulate immune responses and promote tissue repair.
Induced Pluripotent Stem Cells (iPSCs):
Adult cells reprogrammed to an embryonic-like state, capable of differentiating into various cell types, including insulin-producing cells.
Treatment Process
Cell Processing:
The harvested stem cells are processed in a laboratory to enhance their viability and regenerative capabilities.
Administration:
The processed stem cells are reintroduced into the patient, usually through intravenous infusion or direct injection into the pancreas.
Monitoring and Follow-up:
Patients are closely monitored for changes in blood sugar levels, insulin requirements, and any potential side effects.
Potential Benefits
Enhanced Glycemic Control: Improved insulin production and sensitivity can lead to better blood sugar regulation.
Reduced Medication Dependency: Patients may experience a decreased need for insulin or other diabetes medications.
Quality of Life Improvement: With better disease management, patients may experience fewer complications and an improved quality of life.
